Driving guidelines and restrictions in patients with a history of cardiac arrhythmias, syncope,or implantable devices

Dan Sorajja, Win Kuang Shen

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The need to drive is universal in many countries. Patients with syncope, cardiac arrhythmias, or implantable cardioverter-defibrillators (ICDs) have an ongoing risk of sudden incapacitation that may cause harm to themselves and/or others when driving. Restrictions on driving and driving guidelines have been developed with the intent to reduce and prevent motor vehicle accidents, thereby improving personal and public safety. Several guidelines and consensus statements recently were updated. This review focuses on the syncope-related driving guidelines and restrictions. Driving issues related to other causes of loss of consciousness, such as drug or alcohol intoxication, epilepsy, or metabolic disorders, are not included in this review. Approximately 1% to 3% of all motor vehicle accidents are caused by the driver's sudden incapacitation; of these accidents, 5% to 10% are related to cardiac causes, with or without syncope. Major cardiac causes of syncope are neurally mediated mechanisms, bradycardia, and tachycardia. When the cause of syncope is determined and adequately treated, no driving restrictions are usually required after treatment is implemented. Patients who receive ICD therapy for primary or secondary sudden cardiac death prevention are at risk for future device discharges and sudden incapacitation whether or not they are driving. When the cause of syncope is unknown, the response to treatment is uncertain (such as treating the neurocardiogenic/vasovagal syncope), or ICD discharge is possible, driving recommendations are based on the estimation of "risk of harm while driving" and the general consensus on the threshold of "acceptable risk of harm." The annual risk of harm while driving can be estimated by the following formula: driving time (%) × vehicle type (commercial to private) × annual risk of syncope or incapacitation × probability of injury or accident.

Original languageEnglish (US)
Pages (from-to)443-456
Number of pages14
JournalCurrent Treatment Options in Cardiovascular Medicine
Volume12
Issue number5
DOIs
StatePublished - Oct 2010

Fingerprint

Syncope
Cardiac Arrhythmias
Guidelines
Equipment and Supplies
Accidents
Implantable Defibrillators
Vasovagal Syncope
Motor Vehicles
Alcoholic Intoxication
Unconsciousness
Sudden Cardiac Death
Bradycardia
Tachycardia
Epilepsy
Therapeutics
Safety
Wounds and Injuries
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Driving guidelines and restrictions in patients with a history of cardiac arrhythmias, syncope,or implantable devices. / Sorajja, Dan; Shen, Win Kuang.

In: Current Treatment Options in Cardiovascular Medicine, Vol. 12, No. 5, 10.2010, p. 443-456.

Research output: Contribution to journalArticle

@article{c6bd85d58c564b6d9d6db80f4bb56f88,
title = "Driving guidelines and restrictions in patients with a history of cardiac arrhythmias, syncope,or implantable devices",
abstract = "The need to drive is universal in many countries. Patients with syncope, cardiac arrhythmias, or implantable cardioverter-defibrillators (ICDs) have an ongoing risk of sudden incapacitation that may cause harm to themselves and/or others when driving. Restrictions on driving and driving guidelines have been developed with the intent to reduce and prevent motor vehicle accidents, thereby improving personal and public safety. Several guidelines and consensus statements recently were updated. This review focuses on the syncope-related driving guidelines and restrictions. Driving issues related to other causes of loss of consciousness, such as drug or alcohol intoxication, epilepsy, or metabolic disorders, are not included in this review. Approximately 1{\%} to 3{\%} of all motor vehicle accidents are caused by the driver's sudden incapacitation; of these accidents, 5{\%} to 10{\%} are related to cardiac causes, with or without syncope. Major cardiac causes of syncope are neurally mediated mechanisms, bradycardia, and tachycardia. When the cause of syncope is determined and adequately treated, no driving restrictions are usually required after treatment is implemented. Patients who receive ICD therapy for primary or secondary sudden cardiac death prevention are at risk for future device discharges and sudden incapacitation whether or not they are driving. When the cause of syncope is unknown, the response to treatment is uncertain (such as treating the neurocardiogenic/vasovagal syncope), or ICD discharge is possible, driving recommendations are based on the estimation of {"}risk of harm while driving{"} and the general consensus on the threshold of {"}acceptable risk of harm.{"} The annual risk of harm while driving can be estimated by the following formula: driving time ({\%}) × vehicle type (commercial to private) × annual risk of syncope or incapacitation × probability of injury or accident.",
author = "Dan Sorajja and Shen, {Win Kuang}",
year = "2010",
month = "10",
doi = "10.1007/s11936-010-0088-3",
language = "English (US)",
volume = "12",
pages = "443--456",
journal = "Current Treatment Options in Cardiovascular Medicine",
issn = "1092-8464",
publisher = "Current Science, Inc.",
number = "5",

}

TY - JOUR

T1 - Driving guidelines and restrictions in patients with a history of cardiac arrhythmias, syncope,or implantable devices

AU - Sorajja, Dan

AU - Shen, Win Kuang

PY - 2010/10

Y1 - 2010/10

N2 - The need to drive is universal in many countries. Patients with syncope, cardiac arrhythmias, or implantable cardioverter-defibrillators (ICDs) have an ongoing risk of sudden incapacitation that may cause harm to themselves and/or others when driving. Restrictions on driving and driving guidelines have been developed with the intent to reduce and prevent motor vehicle accidents, thereby improving personal and public safety. Several guidelines and consensus statements recently were updated. This review focuses on the syncope-related driving guidelines and restrictions. Driving issues related to other causes of loss of consciousness, such as drug or alcohol intoxication, epilepsy, or metabolic disorders, are not included in this review. Approximately 1% to 3% of all motor vehicle accidents are caused by the driver's sudden incapacitation; of these accidents, 5% to 10% are related to cardiac causes, with or without syncope. Major cardiac causes of syncope are neurally mediated mechanisms, bradycardia, and tachycardia. When the cause of syncope is determined and adequately treated, no driving restrictions are usually required after treatment is implemented. Patients who receive ICD therapy for primary or secondary sudden cardiac death prevention are at risk for future device discharges and sudden incapacitation whether or not they are driving. When the cause of syncope is unknown, the response to treatment is uncertain (such as treating the neurocardiogenic/vasovagal syncope), or ICD discharge is possible, driving recommendations are based on the estimation of "risk of harm while driving" and the general consensus on the threshold of "acceptable risk of harm." The annual risk of harm while driving can be estimated by the following formula: driving time (%) × vehicle type (commercial to private) × annual risk of syncope or incapacitation × probability of injury or accident.

AB - The need to drive is universal in many countries. Patients with syncope, cardiac arrhythmias, or implantable cardioverter-defibrillators (ICDs) have an ongoing risk of sudden incapacitation that may cause harm to themselves and/or others when driving. Restrictions on driving and driving guidelines have been developed with the intent to reduce and prevent motor vehicle accidents, thereby improving personal and public safety. Several guidelines and consensus statements recently were updated. This review focuses on the syncope-related driving guidelines and restrictions. Driving issues related to other causes of loss of consciousness, such as drug or alcohol intoxication, epilepsy, or metabolic disorders, are not included in this review. Approximately 1% to 3% of all motor vehicle accidents are caused by the driver's sudden incapacitation; of these accidents, 5% to 10% are related to cardiac causes, with or without syncope. Major cardiac causes of syncope are neurally mediated mechanisms, bradycardia, and tachycardia. When the cause of syncope is determined and adequately treated, no driving restrictions are usually required after treatment is implemented. Patients who receive ICD therapy for primary or secondary sudden cardiac death prevention are at risk for future device discharges and sudden incapacitation whether or not they are driving. When the cause of syncope is unknown, the response to treatment is uncertain (such as treating the neurocardiogenic/vasovagal syncope), or ICD discharge is possible, driving recommendations are based on the estimation of "risk of harm while driving" and the general consensus on the threshold of "acceptable risk of harm." The annual risk of harm while driving can be estimated by the following formula: driving time (%) × vehicle type (commercial to private) × annual risk of syncope or incapacitation × probability of injury or accident.

UR - http://www.scopus.com/inward/record.url?scp=77956269122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956269122&partnerID=8YFLogxK

U2 - 10.1007/s11936-010-0088-3

DO - 10.1007/s11936-010-0088-3

M3 - Article

C2 - 20842566

AN - SCOPUS:77956269122

VL - 12

SP - 443

EP - 456

JO - Current Treatment Options in Cardiovascular Medicine

JF - Current Treatment Options in Cardiovascular Medicine

SN - 1092-8464

IS - 5

ER -